Hostname: page-component-5c6d5d7d68-lvtdw Total loading time: 0 Render date: 2024-08-19T00:54:13.452Z Has data issue: false hasContentIssue false
  • English
  • Français

The Impact of Screening Psychiatric Comorbidity and High-risk Feedback on Liaison Psychiatric Consultation Rates and Clinicians’ Attitudes on a Neurology Ward

Published online by Cambridge University Press:  23 March 2020

R. Van Damme ,
G. Portzky ,
P. Boon  and
G.M.D. Lemmens
R. Van Damme
Affiliation:
Department of Psychiatry, Ghent University Hospital, GhentBelgium
G. Portzky
Affiliation:
Department of Psychiatry, Ghent University Hospital, GhentBelgium
P. Boon
Affiliation:
Department of Neurology, Ghent University Hospital, Ghent, Belgium
G.M.D. Lemmens
Affiliation:
Department of Psychiatry, Ghent University Hospital, GhentBelgium

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Lifetime prevalence of psychiatric comorbidity in neurological patients is as high as 55%, but it remains often undetected and therefore untreated in hospital settings. Further, clinicians tend to make little use of the consultative and liaison psychiatric team for detection and treatment of anxiety and mood disorders in neurological patients. The current study aimed to investigate whether the implementation of a stepped screening protocol with high risk feedback to the clinician had an influence on the use of consultative and liaison psychiatric services.

Method

All patients admitted to the neurological ward were assessed using a stepped screening protocol for depression, anxiety and substance use during 15 months. Positive screening resulted in feedback to the clinicians depending on the study phase (e.g. feedback vs. no feedback).

Results

No differences were found in the use of consultative and liaison psychiatric services during the non-feedback and feedback phase.

Conclusion

Screening and high risk feedback of psychiatric comorbidity in neurological patients does not increase psychiatric referral rates. It points to the necessity of a more integrated collaborative care model for detection and treatment of psychiatric comorbidity.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
Workshop: To screen or not to screen?
Information
European Psychiatry , Volume 41 , Issue S1: Abstract of the 25th European Congress of Psychiatry , April 2017 , pp. S53
Copyright
Copyright © European Psychiatric Association 2017
Submit a response

Comments

No Comments have been published for this article.